Orthofix to Present at Canaccord Genuity Growth Conference

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V. (NASDAQ: OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that President and Chief Executive Officer Brad Mason will present at the Canaccord Genuity Growth Conference in Boston on Wednesday, August 8, 2018 at 11:00 a.m. ET.

A live audio webcast will be available on the Company’s website at ir.orthofix.com/events.cfm.

About Orthofix

Orthofix International N.V. is a global medical device company focused on musculoskeletal products and therapies. The Company’s mission is to improve patients' lives by providing superior reconstruction and regenerative musculoskeletal solutions to physicians worldwide. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedic extremities products are distributed in over seventy countries via the Company's sales representatives and distributors. For more information, please visit www.orthofix.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180731005925/en/

Orthofix International N.V.
Investor Contact:
Mark Quick, 214-937-2924
[email protected]
or
Media Contact:
Denise Landry, 214-937-2529
[email protected]

Source: Orthofix International N.V.

You May Also Be Interested In

• Orthofix to Report Second Quarter 2026 Financial Results
• Unipart, KBR and IBM launch Team ORION to future-proof defence operations
• Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026